Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
  • India

    Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

    Siddhant Pandey
    Written by
    Siddhant Pandey
    Twitter
    Last updated on Jan 03, 2021, 10:12 am
    Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
  • A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.

    The panel submitted its findings to the Drugs Controller General of India (DCGI), who will take a final call on the issuance of EUA.

    Covishield—the vaccine developed by AstraZeneca and Oxford University, and manufactured by Pune-based Serum Institute of India—has also received the panel's nod.

  • In this article
    CDSCO panel recommends 'restricted use in emergency situation' Recommendation comes despite lack of efficacy data 'We have very robust Phase I and II results' Panel had recommended nod to Covishield on Friday Pfizer-BioNTech vaccine also awaiting emergency approval grant India had held dry run for vaccine delivery yesterday
  • Panel

    CDSCO panel recommends 'restricted use in emergency situation'

    CDSCO panel recommends 'restricted use in emergency situation'
  • The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation (CDSCO) had on Saturday recommended the "grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains, to M/s Bharat Biotech International Ltd, Hyderabad," the Union Health Ministry said.

  • Trial data

    Recommendation comes despite lack of efficacy data

  • Notably, the panel's recommendation comes despite a lack of trial data indicating the vaccine's efficacy.

    COVAXIN has completed two out of three clinical trials so far. The third trial—which had started in November—tests for vaccine efficacy.

    Bharat Biotech said it has successfully recruited 23,000 out of 26,000 Phase III trial volunteers.

    Phase I and II trials had shown positive safety and immunogenicity results.

  • Information

    'We have very robust Phase I and II results'

  • Dr. Savita Verma—a pharmacology professor from Haryana's PGIMS working on the vaccine—told NDTV, "We have very robust Phase I and II results, in which good efficacy was shown." Dr. Verma also said that around 10 million doses of COVAXIN are ready.

  • Covishield

    Panel had recommended nod to Covishield on Friday

    Panel had recommended nod to Covishield on Friday
  • Earlier on Friday, the CDSCO panel had recommended Covshield for approval as well.

    The vaccine will "protect 95% of (its) patients," AstraZeneca CEO Pascal Soriot had said last week.

    Serum Institute CEO Adar Poonawalla has said that roughly 50 million doses, most of which will go to India, are already stockpiled.

    India will also be contributing doses to the global COVAX facility.

  • Information

    Pfizer-BioNTech vaccine also awaiting emergency approval grant

  • The vaccine developed by Pfizer and BioNTech, Tozinameran or BNT162b2, is also under review by the CDSCO panel for emergency approval in India. The company is reportedly yet to present its data before the panel. The vaccine has notably been approved in several countries.

  • Recent news

    India had held dry run for vaccine delivery yesterday

    India had held dry run for vaccine delivery yesterday
  • The government had on Saturday conducted a day-long trial run of the vaccine delivery system to check for potential challenges.

    The exercise was conducted in 116 districts and nearly one lakh personnel had undergone the necessary training, the Health Ministry said.

    Health Minister Dr. Harsh Vardhan said Sunday morning that there should be no misconceptions about vaccines approved in India.

  • Oxford University
  • Health Ministry
  • Union Health Ministry
  • CDSCO
  • Drugs Controller General of India
  •  
Latest News
  • WI beat SL in 3rd T20I, win series: Records broken
    WI beat SL in 3rd T20I, win series: Records broken
    Sports
  • Bale, Kane help Spurs defeat Crystal Palace 4-1: Records broken
    Bale, Kane help Spurs defeat Crystal Palace 4-1: Records broken
    Sports
  • MacKenzie Scott, former wife of Jeff Bezos, marries school teacher
    MacKenzie Scott, former wife of Jeff Bezos, marries school teacher
    World
  • Royals fretted over Archie's skin color: Meghan Markle tells Oprah
    Royals fretted over Archie's skin color: Meghan Markle tells Oprah
    World
  • Coronavirus: India's tally reaches 11.22 million with 18K+ new cases
    Coronavirus: India's tally reaches 11.22 million with 18K+ new cases
    India
Related Timelines
  • COVAXIN 81% effective, offers protection against UK variant: Bharat Biotech
    COVAXIN 81% effective, offers protection against UK variant: Bharat Biotech
    Science
  • SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    India
  • COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns
    COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns
    India
  • All you need to know about vaccines approved in India
    All you need to know about vaccines approved in India
    India
Trending Topics
ISRO Vaccine
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Twitter Indian Premier League Samsung Virat Kohli
Rohit Sharma Cricket News Narendra Modi Facebook YouTube Hollywood News WhatsApp Bollywood News ISRO Yoga
Saif Ali Khan Honda Batman Football News BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Royal Challengers Bangalore
Toyota Fashion Tips Amit Shah Mercedes La Liga Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV
Vinesh Phogat Marvel Comics Avengers Neha Kakkar
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021